Illness	Number of cases
Cerebral aneurysm nonruptured (I67.10)	198
Benign neoplasm of meninges - Benign neoplasm of cerebral meninges (D32.0)	121
Intracranial injury (S06.5)	92
Phakomatoses not elsewhere classified (Q85.0)	75
Benign neoplasm of other and unspecified endocrine glands - Benign neoplasm of pituitary gland (D35.2)	46
Spread metastasis of cancer in otherwise unspecified areas of the body (C79.3)	43
Intracranial injury (S06.6)	40
Malignant neoplasm of brain - Malignant neoplasm of temporal lobe (C71.2)	38
Malignant neoplasm of brain - Malignant neoplasm of frontal lobe (C71.1)	34
Other intervertebral disc disorders (M51.1)	31

Top 10 treatments

Treatment	Number
Computed tomography (CT) of the head without contrast medium (3-200)	1.047
Computer assisted visualisation of body structures in 3 dimensions - virtual 3D reconstruction technique (3-994)	791
X-rays of the arteries of the neck with contrast medium (3-601)	659
Magnetic resonance imaging (MRI) of the head with contrast medium (3-820)	547
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	460
Radiotherapy with high-energy beams for cancer - high voltage radiotherapy (8-522.91)	414
Operation using aids for optical magnification, e.g. magnifying spectacles, operating microscope (5-984)	394
X-rays of the arteries in the head with contrast medium (3-600)	250
Magnetic resonance imaging (MRI) of the spine and spinal cord with contrast medium (3-823)	240
Operation using a navigation system which produces real-time 3-D images of the surgical site during the operation (5-988.3)	200

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 1700

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ02
CQ03	über Tumorboard
CQ05	Weiterführende standortbezogene Informationen unter: www.perinatalzentren.org
CQ25
CQ04

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
313	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
218	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
209	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities	Lehre und Lehrauftrag der HMU Erfurt, an den Universitäten Jena, München, Frankfurt, Freiburg, Regensburg, Greifswald, Technische Universität Ilmenau
Lectureships / teaching posts at universities of applied sciences	Mentorenprojekt der LÄK Thüringen, EANS-Observership-Programm (mit internationalen Fachärzten und AiW)
Project-related cooperation with colleges and universities	u.a.Uni Jena, Uni Leipzig, IMTEK Freiburg, Neurochirurgie Uni Freiburg, HNO Uni Saarbrücken, Psychologie Uni Giessen, Neurofibromatoseambulanz Uni Hamburg
Participation in multi-centre Phase I/II studies	u.a. ADRISK: Multicenter randomized Phase II study within the German interdisciplinary study group of German Cancer Society (IAG KHT) IMSTAR HN: Multicenter randomized controlled phase III study.
Participation in multi-centre phase III/IV studies
Initiation and management of uni-centric/multi-centric clinical/scientific studies	Uni Jena, Uni Leipzig
Student training (clinical traineeship / internship year)
Editors of scientific journals/textbooks	u.a. Lehrbuch Biomedizinische Technik, Band XI: Neurotechnik
Doctoral supervision	Universitätsmedizin Jena, Greifswald